Genomics Biotechnology & Emerging Medical Technologies Institute e-News Archive

Medicaid expansion improves access to care, population health

States that did not opt into Medicaid expansion under the Affordable Care Act experienced worse emergency access to acute care hospitals compared to states that did, according to recent study. Overall, states that expanded Medicaid saw...

source: HealthPayerIntelligence

ACOs, population-based APMs most effective at lowering costs

If CMS aims to lower healthcare costs and improve quality, then the agency should use more population-based alternative payment models, like accountable care organizations, according to a new analysis. The analysis of the evaluations for more than a dozen CMS value-based...

source: RevCycleIntelligence

FDA approves additional dosing option of durvalumab for stage III NSCLC, advanced bladder cancer

The FDA has approved an additional dosing option of durvalumab: a 1500 mg fixed dose administered every 4 weeks for the treatment of unresectable stage III non-small cell lung cancer after chemoradiation therapy and previously...

source: Cancer Network

Eli Lilly arthritis drug gets FDA nod for emergency use with remdesivir to treat COVID-19

The U.S. Food and Drug Administration on Nov. 19 approved the emergency use of Eli Lilly’s arthritis drug baricitinib, in combination with Gilead Sciences’ remdesivir, to treat COVID-19 patients. The approval...

source: CNBC

Accessing care in the new normal: Some healthcare consumers prefer combination of in-person, virtual care post-COVID-19

DocASAP, the health industry's most advanced patient access and engagement platform for health systems, health plans and physician groups, announced the results of its second annual “State of Patient Access and Engagement” 2020 survey.

source: Managed Healthcare Executive

What does it take to be a successful, reimbursable health promotion program?

Building relationships with state Medicaid agencies and local health plans is essential for sharing the value of evidence-based health promotion and disease prevention programs and obtaining reimbursement for those efforts, according...

source: Managed Healthcare Executive

Unraveling a mystery surrounding embryonic cells

Last year, researchers identified the early origins of neural crest cells — embryonic cells in vertebrates that travel throughout the body and generate many cell types — in chick embryos. Now the researchers have used a human model to figure out when neural crest...

source: University of California - Riverside via ScienceDaily

Stem cell transplantation: Undesirable rejection mechanism identified

In the treatment of leukemia, stem cell transplantation subsequent to chemotherapy and radiation can often engender severe adverse inflammatory reactions — especially in the skin or in the gut, since these so-called barrier organs...

source: Medical University of Vienna via ScienceDaily

New personalized medicine report shows record-setting growth to 286 in number of personalized medicines available, documents challenges in regulation, reimbursement, clinical adoption

The Personalized Medicine Coalition released a newly updated overview of the state of personalized medicine with reference to the latest advancements in research and clinical...

source: Yahoo Finance

The critical importance of patent protection for diagnostics in the COVID-19 era

The COVID-19 pandemic has highlighted the importance of patent eligibility in the diagnostic industry like never before. From the beginning of the pandemic, testing has been at the forefront of response efforts all over the world....

source: Medical Device and Diagnostic Industry

Turning the problem of cancer metastasis into an opportunity

When a patient with cancer is told the devastating news that their disease has spread, or metastasized, to a new part of their body, it has most often moved to their lungs. There are no treatments approved for lung metastasis, which is the leading cause of death from metastatic...

source: The Harvard Gazette

Report highlights how tracking technologies will become part of everyday medicine by 2025

Vicon, a world leader in motion capture for the life sciences industry, announces the launch of its latest vision paper highlighting some of the key trends and developments that will determine the future of motion capture...

source:

CRISPR technique effectively destroys metastatic cancer cells in living animal

Scientists at Tel Aviv University report that the CRISPR/Cas9 system is effective in treating metastatic cancers, which they say marks a significant step on the way to finding a cure for cancer. The researchers developed a lipid...

source: Genetic Engineering & Biotechnology News

Lack of awareness of the sensitivity of DNA data

In both ethical and scientific respects, Roma population groups are treated inappropriately in DNA databases and in genetic studies — potentially with consequences for investigations that draw on forensic genetic databases: this was the conclusion of Prof. Dr. Veronika...

source: Medical Xpress

A DNA-based nanogel for targeted chemotherapy

Current chemotherapy regimens slow cancer progression and save lives, but these powerful drugs affect both healthy and cancerous cells. Now, researchers have designed DNA-based nanogels that only break down and release their chemotherapeutic contents within cancer cells,...

source: American Chemical Society via ScienceDaily

Subscribe to Genomics Biotechnology & Emerging Medical Technologies Institute e-News

*Email:
*First Name:
*Last Name:
*Company:
Title:
Street Address:
City:
State / Province:
Zip / Postal Code:
Country:

Are you a member of NAMCP?	Yes No


Privacy Policy

Browse Categories

Browse by Date

Report: Interoperability does not affect EHR buying decision

Medicaid expansion improves access to care, population health

ACOs, population-based APMs most effective at lowering costs

FDA approves additional dosing option of durvalumab for stage III NSCLC, advanced bladder cancer

Eli Lilly arthritis drug gets FDA nod for emergency use with remdesivir to treat COVID-19

Accessing care in the new normal: Some healthcare consumers prefer combination of in-person, virtual care post-COVID-19

What does it take to be a successful, reimbursable health promotion program?

Unraveling a mystery surrounding embryonic cells

Stem cell transplantation: Undesirable rejection mechanism identified

New personalized medicine report shows record-setting growth to 286 in number of personalized medicines available, documents challenges in regulation, reimbursement, clinical adoption

The critical importance of patent protection for diagnostics in the COVID-19 era

Turning the problem of cancer metastasis into an opportunity

Report highlights how tracking technologies will become part of everyday medicine by 2025

CRISPR technique effectively destroys metastatic cancer cells in living animal

Lack of awareness of the sensitivity of DNA data

A DNA-based nanogel for targeted chemotherapy

RECOMMENDED:

Subscribe to Genomics Biotechnology & Emerging Medical Technologies Institute e-News